Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Beta-Citronellene SCHEMBL21872 | 1.00 | ALOX15 (0.50) | ALOX15ALDH1A1TSHRSRCKMT2A | |
| Beta-Citronellene SCHEMBL2456981 | 1.00 | ALOX15 (0.50) | ALOX15ALDH1A1TSHRSRCKMT2A | |
| Beta-Citronellene SCHEMBL5179143 | 0.92 | ALOX15 (0.44) | ALOX15ALDH1A1TSHRUSP2 | |
| Beta-Citronellene SCHEMBL9877861 | 0.90 | ALOX15 (0.42) | ALOX15ALDH1A1TSHRSRC | |
| SCHEMBL25333837 | 0.88 | KMT2A (0.57) | ALOX15ALDH1A1KMT2A | |
| SCHEMBL9484275 | 0.88 | KMT2A (0.57) | ALOX15ALDH1A1KMT2A | |
| SCHEMBL11620500 | 0.88 | KMT2A (0.57) | ALOX15ALDH1A1KMT2A | |
| SCHEMBL28674581 | 0.88 | KMT2A (0.57) | ALOX15ALDH1A1KMT2A | |
| SCHEMBL4623731 | 0.88 | KMT2A (0.57) | ALOX15ALDH1A1KMT2A | |
| SCHEMBL11337182 | 0.88 | KMT2A (0.57) | ALOX15ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4319716-A1 | COMPOSITIONS TO LIMIT, REDUCE OR ELIMINATE MALODOURS ASSOCIATED WITH PLASTIC MATERIALS | Firmenich SA (CH) | 2024-02-14 | — | — | EP | claimed |
| WO-2022253712-A1 | COMPOSITIONS TO LIMIT, REDUCE OR ELIMINATE MALODOURS ASSOCIATED WITH PLASTIC MATERIALS | FIRMENICH SA (CH) | 2022-12-08 | — | — | WO | claimed |
| EP-3639847-B1 | HORSE FEED SUPPLEMENT AND ITS USE | THAROS LTD (GB) | 2026-05-06 | — | — | EP | disclosed |
| US-12290591-B2 | Fragrance compositions | FIRMENICH SA (CH) | 2025-05-06 | — | — | US | disclosed |
| CN-117377527-A | Polyamide-based microcapsules | 弗门尼舍有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-20220096355-A1 | FRAGRANCE COMPOSITIONS | FIRMENICH SA (CH) | 2022-03-31 | — | — | US | disclosed |
| EP-3639847-A1 | HORSE FEED SUPPLEMENT AND ITS USE | Pepsis Limited (GB) | 2020-04-22 | — | — | EP | disclosed |
| US-9765003-B2 | Process for producing 2,6-dimethyl-5-hepten-1-al | BASF SE (DE) | 2017-09-19 | — | — | US | disclosed |
| US-20170183280-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | BASF SE (DE) | 2017-06-29 | — | — | US | disclosed |
| EP-3140272-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | BASF SE (DE) | 2017-03-15 | — | — | EP | disclosed |
| WO-2015169721-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | BASF SE (DE) | 2015-11-12 | — | — | WO | disclosed |
| US-9156874-B2 | Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs | NANJING MOLECULAR RESEARCH, INC. (CN) | 2015-10-13 | — | — | US | disclosed |
| EP-2825059-A2 | ANIMAL FEED SUPPLEMENT AND ASSAY METHOD | The University of Birmingham (GB) | 2015-01-21 | — | — | EP | disclosed |
| WO-2013136069-A2 | DIETARY SUPPLEMENT AND ASSAY METHOD | THE UNIVERSITY OF BIRMINGHAM (GB) | 2013-09-19 | — | — | WO | disclosed |
| WO-2012171652-A1 | SYNTHESIS OF VITAMIN E | XIMO AG (CH) | 2012-12-20 | — | — | WO | disclosed |
| EP-0647647-B1 | Tertiary phosphine compound and transition metal complex comprising the same as ligand | SUMITOMO CHEMICAL CO (JP) | 2001-10-24 | — | — | EP | disclosed |
| US-5523437-A | Tertiary phosphine compound and transition metal complex comprising the same as ligand | SUMITOMO CHEMICAL CO., LTD. (JP) | 1996-06-04 | — | — | US | disclosed |
| EP-0647647-A1 | Tertiary phosphine compound and transition metal complex comprising the same as ligand | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170183280-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | CYP8B1, CYP51A1, MSMO1 | ALOX15 57/4885ALDH1A1 423/4885TSHR 4850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.